Clinical trial
Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung…
NCT00284154 · SCRI Development Innovations, LLC, Other · Completed
Key facts
| NCT number | NCT00284154 |
|---|---|
| Title | Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer |
| Official title | A Phase II Trial of VInflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer |
| Lead sponsor | SCRI Development Innovations, LLC, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Small Cell, Lung Cancer |
| Intervention type | Drug |
| Interventions | Vinflunine |
| Enrollment | 51 |
| Start date | Jan 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Jan 31, 2006 |
| Last update posted | Mar 13, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: